9D6-69621-05605
4 vaccinations
4 coded responses
33 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 502 / IA
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Moderna
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
-
2021-03-18
Dose 2 — Moderna
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-06-17
-
2021-09-16
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Cough, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Severe coughing, fever, loss of taste & smell.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Dose 3 — Moderna
-
2021-10-28
Survey response — day 28, dose 3MedDRA: Ageusia, Anosmia, Cough, Decreased appetite, Fatigue, Malaise, Medical counselling, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Positive COVID-19 test 8/18/2021. Fever, malaise, severe coughing, loss of taste & smell, & appetite, extreme fatigue. Did NOT require Hospitalization. Pulse Ox remained in 86-89% range x10 days. Tx of symptoms, NO OAB, steroids, Z-pack, vit Tx. · Healthcare visit (other): Phone conversationsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-01
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-04-09
Dose 4 — Moderna
-
2022-04-25
Survey response — day 14, dose 4MedDRA: Erythema, Fatigue, Inflammation, Injection site pain, Malaise — Feeling: GoodFree text: Approx. 36 hrs of inflammation, redness & sore arm @ injection site, general malaise and fatigue after injection.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-30
- 2022-05-07
- 2022-05-14
- 2022-05-21
-
2022-07-09
Survey response — 3 months, dose 4MedDRA: Asthenia, Diarrhoea, Fatigue, Gastroenteritis, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: Gastroenteritis w/vomiting x6 days & loose stools x2 days. Weakness & fatigue x21 days. Does NOT appear related to vaccine or COVID.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2023-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Moderna | |
| 2 | 2021-03-18 | Moderna | |
| 3 | 2021-09-29 | Moderna | No |
| 4 | 2022-04-09 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Severe coughing, fever, loss of taste & smell.
Release 10 — day 28, dose 3
Symptoms: Positive COVID-19 test 8/18/2021. Fever, malaise, severe coughing, loss of taste & smell, & appetite, extreme fatigue. Did NOT require Hospitalization. Pulse Ox remained in 86-89% range x10 days. Tx of symptoms, NO OAB, steroids, Z-pack, vit Tx.
Healthcare visit (other): Phone conversations
Release 11 — day 14, dose 4
Symptoms: Approx. 36 hrs of inflammation, redness & sore arm @ injection site, general malaise and fatigue after injection.
Release 12 — 3 months, dose 4
Symptoms: Gastroenteritis w/vomiting x6 days & loose stools x2 days. Weakness & fatigue x21 days. Does NOT appear related to vaccine or COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Erythema | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastroenteritis | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release